Tipping Point Stocks | Market Analysts

20 Jan TPS Research Report

Posted at 09:12h in Research Reports

SNSS 3.10 6-12 month target $8.25 plus Viracta Website Viracta is committed to advancing new medicines to benefit patients with viral-associated cancers and other serious diseases. Viracta’s proprietary platform is a highly targeted combination therapy approach for virus-associated malignancies. Our initial focus is on cancers associated with the Epstein...

19 Jan TPS Portfolio Quick Notes

Posted at 08:42h in Portfolio Updates

MEEC announced today the 4th major coal utility has now settled as projected by me in the initial write up and last weeks update. The stock should continue higher as the little guys all fall in line this year. $1.20 remains low end 12 month...

14 Jan LTRN Update and Buy Advisory

Posted at 20:29h in Portfolio Updates

LTRN 14.50 close of 1/14- STRONG BUY TO 16 on Offering Dip! Lantern just saw an air pocket drop from $21 to $14 in the past week or so as word got out on a 2.6M share offering. With only 6.5 Million shares outstanding and not...

13 Jan TPS Research Report- MARA

Posted at 10:31h in Research Reports

MARA 22.50 88 Million shares after this direct offering closes this week at $20 per share Here are some more details on why I like this position as a defacto ETF of Bitcoin ownership if you will. At $22 MARA has a market cap of 1.95 Billion MARA can...

13 Jan TPS Buy Alert- MARA

Posted at 09:27h in Research Reports

MARA $22 pre market down $4 I will post much more research and outlined details, but this is a fast mover and I have been waiting for a pullback. MARA is a Bitcoin miner and with Bitcoin as one of my ongoing growth themes, we can own...

12 Jan TPS Portfolio Updates

Posted at 09:12h in Portfolio Updates

TPS updates- Working actively on research on new positions, updates on existing positions, and what new members can buy now Lots of new members, so here is advice for those recently joining below and updates on all positions for everyone. We have been on fire with...

04 Jan PRVB closing out for 70% final gains

Posted at 12:50h in Portfolio Updates

PRVB 17.60 It's up today in a down market on the FDA accepting the BLA for Teplizumab. That said, we are taking the gains of 70% on the final 1/2 after 18 months of holding this stock. This could continue to work higher but we are...

29 Dec TPS Portfolio and Position Notes

Posted at 08:29h in Portfolio Updates

Dave Banister, Chief Strategist, Themarketanalysts.com The markets remain a bit extended but we also just had a nice 3 week consolidation in the SP 500 and could still work up to my 3996 Major 5 target over next several weeks. There are plenty of money supply...

23 Dec Closing out TBIO for 50% gains on Final 2/3

Posted at 10:03h in Uncategorized

TBIO 22.88 Avg net entry around 15-15.50 Closing this out as Vaccine stocks are losing luster, this may do very well long term. That said, we sold 1/3 for 75-80% gains at 27.50 a few weeks ago, now closing out to make room for new 1st quarter...

21 Dec TPS Position Updates and Charts

Posted at 10:07h in Portfolio Updates

Today I am doing some quick updates on our 9 portfolio names , I plan to have 3 more with 12 being the max. Each position should be about 8% of a TPS allocation portfolio. Obviously I weight this in smaller cap names and Biotech in...